Dr. Hanady Yousef Shourrab is a strategic and results-driven Senior Pharmacist with over a decade of experience at the UAE Ministry of Health & Prevention. She has 13 years of experience in retail pharmacy and is known for pioneering digital transformation initiatives in pharmaceutical regulation.

Holding a Master’s in Pharmaceutical Technology and pursuing a Ph.D. in Pharmaceutical Sciences, Dr. Hanady excels in optimizing compliance processes, fostering inter-departmental collaboration, and leveraging expertise in Import & Export, Registration, and Pharmacovigilance. She has a proven track record in representing the department at international conferences and driving performance enhancements.

Dr. Nisreen Mohammad Nassr is a distinguished pharmaceutical executive with over 22 years of expertise in regulatory affairs and strategic leadership. Dr. Nassr holds an MSc in Pharmaceutical Science with distinction from the University of East London, UK, and certified lean six sigma black belt. As the Director of Drug Control at the Ministry of Health in Oman, Dr. Nisreen has demonstrated strong commitment to regulatory compliance and alignment with international standards. She has been instrumental in formulating strategies that optimize market responsiveness and improve medication availability. Her leadership includes oversight of cross-functional teams, risk management, and stakeholder engagement with global regulatory authorities

Ph. Muna Al Saidi stands as a dedicated professional at the forefront of healthcare administration, currently holding the esteemed position of Section Head in the Registration Section of Human Medicine at the Ministry of Health, Oman. With a passion for ensuring the seamless operation of medical registration processes, Muna Al Saidi has become a respected figure in the healthcare sector of Oman.

Known for her strategic vision and meticulous attention to detail, Muna Al Saidi has played a pivotal role in streamlining registration procedures within the Ministry of Health. Her commitment to excellence has not only earned her the trust of her colleagues but has also contributed significantly to the overall efficiency of the healthcare system in Oman.
As a seasoned leader, Muna Al Saidi brings a wealth of experience to her role, coupled with a deep understanding of the complexities involved in managing the registration of human medicine. Her dedication to advancing healthcare services reflects a commitment to enhancing the well-being of the Omani population.

• Msc – Supply Chain & Logistic Management (Glasgow, Strathclyde University, UK)
• Master of Pharmacy (M-Pharm) (Liverpool John Moores University, UK)
• Diploma – Pharmacy (Institute of Pharmacy, Oman)
• Positions
• Regulatory Staff – Drug Control Department – Variation Section (November 2022 onwards)
• Director of Medical Store (Laboratory Materials & Supplies)- Directorate General of Medical Supply )2021-2022 )
• Head of Department of Receiving Section – Directorate General of Medical Supply )2019-2021)
• Pharmacist in Quality Department – Directorate General of Medical Supply )2018-2019)
• Head Of Department of Injection Section – Directorate General of Medical Supply )2017- 2018)
• Acting Head of Injection Section – Directorate General of Medical Supply )2016- 2017)
• Acting Head of Syrup Section – Directorate General of Medical Supply )2015-2016)
• Pharmacist in Directorate General of Medical Supply (2011- 2015)
• Pharmacy In charge – Wilayat Bousher  (2008-2011)
• Pharmacist in Al khuwair Health Center  (2003 – 2008)
• Publications
• Lean Practitioners project (Accuracy in Quantifying the annual requirement of lab disposable items ( February 2022 till June 2022)
• Literature review on statins & rhabdomyolysis published in LENS magazine March 2011 Oman
• Acne (Is isoisotretinion the solution?) – The Reflection (Wilayat Muscat Health services Newsletter) on January 2006

She is a seasoned expert in Pharma Policy, Public Affairs, and Regulatory Affairs, with over 30 years of diverse industry experience. Nadia holds a Bachelor’s degree in Pharmacy from Jordan University, a Master’s degree in Healthcare Management from Zayed University, and a Master’s in Public Health (MPH) with a focus on Leadership & Policy from Johns Hopkins University, USA, she also completed two years of advanced DrPH studies in same University.

Nadia’s illustrious career that encompasses roles in both multinational corporations, such as Pfizer and AstraZeneca, and government regulatory authorities. She notably served as the Head of the Registration & Pricing Department at the UAE Ministry of Health, where she played a crucial role in shaping the GCC-UAE regulatory frameworks. Her international engagements include representing the UAE at esteemed platforms like the WHO and the Gulf Health Council.

As the Managing Director of Stellar Pharma Consultancy, Nadia has been a trusted advisor, leading complex regulatory and policy advocacy projects for top multinational pharmaceutical companies.

Currently, she serves as a consultant for Drugs Regulations & Medical Products at the Department of Health-Abu Dhabi, Life Sciences Sector.

Nadia is passionate about advocating for Regulatory System Strengthening (RSS) among regulatory authorities. She actively promotes Regulatory Active Collaborative models to achieve higher Regulatory Maturity Levels. Her work has been presented at workshops and through policy position papers to Medicinal National Regulatory Authorities in Algeria, Pakistan, the Philippines, Kenya, and Turkey.

Dr. Anees Puthan Veettil is a strategic leader with over 20 years of experience in Drug Development, specializing in pharmaceutical studies and clinical trials. He holds a Pharmacy Post-Graduation in Pharmacology from Dr. MGR Medical University, India, and a specialization in Clinical Research & Regulatory Affairs from York College, Canada.

Dr. Veettil currently leads the Evaluation Unit of Pharmaceutical Studies at the Ministry of Health and Prevention in the UAE. He has expertise in Pharmaceutical Studies Evaluation, Clinical Operations, Regulatory Affairs, Quality Assurance, R&D, GMP Audits, and Project Management, with experience working with global pharmaceutical companies like GlaxoSmithKline.

In addition, he is a visiting faculty member at various research and pharmacy institutes and has trained doctors and ethics committees on clinical research.

Education and experience:

– pharmacist, graduated from Hawler medical university (HMU)

College of pharmacy (2014,2015)

-over 8 years experience in regulatory affairs and registration regulations for pharmaceutical sites and products, ensuring:

1.the compliance with national and international regulations, fostering adherence to healthcare standards.

2.Provided expert guidance to pharmaceutical companies, enhancing their understanding of compliance requirements.

Dr. Ahmed Mohamed Al-Ansari is the CEO of the National Health Regulatory Authority (NHRA) in Bahrain. He has extensive experience in the healthcare sector, contributing to the development and improvement of medical services in the kingdom. He expanded emergency departments, increased operating room capacity, and improved infection control, reducing wait times in hospitals. He also played a key role in developing medical curricula and enhancing medical education in Bahrain, aligning the healthcare system with global standards.